MCF Advisors’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,186
Closed -$17.8K 997
2023
Q3
$17.8K Buy
1,186
+269
+29% +$5.6K ﹤0.01% 502
2023
Q2
$29.8K Buy
917
+75
+9% +$2.74K ﹤0.01% 427
2023
Q1
$32.9K Sell
842
-20
-2% -$978 ﹤0.01% 413
2022
Q4
$45.6K Sell
862
-88
-9% -$4.29K ﹤0.01% 355
2022
Q3
$43K Buy
+950
New +$40.9K ﹤0.01% 355

Other funds holding SILK

MCF Advisors's SILK Position: Q4 2023 in Review

MCF Advisors sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q4 2023, closing a stake of 1,186 shares — an estimated $17.8K sold.

MCF Advisors first reported a position in SILK in Q3 2022 and held it in 5 quarters. The position peaked at $45.6K in Q4 2022. 133 funds tracked by Wall St. Rank hold SILK as of Q4 2023.

  • MCF Advisors reported no remaining Silk Road Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • MCF Advisors sold 1,186 Silk Road Medical, Inc. Common Stock shares in Q4 2023, an estimated $17.8K.
  • MCF Advisors first reported a position in Silk Road Medical, Inc. Common Stock in Q3 2022 and held it in 5 quarters.
  • MCF Advisors's Silk Road Medical, Inc. Common Stock position peaked at $45.6K in Q4 2022.
  • 133 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q4 2023.

Based on MCF Advisors's 13F filing for Q4 2023, filed 1 Feb 2024.